In both mouse groups, WT and S1P5−/−, the analysis of skin areas revealed a transcriptional upregulation of ICAM-1, CCR2, CD206, and TGF-β1 in mice treated 2 weeks with BLM related to the respective PBS-injected control groups (Figures 1A–D). Here, CCR2 is linked to Bloom syndrome.